Lynne Brum
Investor Relations Kontakt bei YIELD10 BIOSCIENCE, INC.
Vermögen: 9 560 $ am 30.04.2024
Profil
Lynne H.
Brum is currently working as the Secretary, VP-Planning & Communications at Yield10 Bioscience, Inc. She previously worked as a Director at Altus Pharmaceuticals, Inc. and Seidler Bernstein, Inc. as a Director-Freelance Project.
She also held positions as Vice President-Corporate Communications & Research at Biogen MA, Inc., Vice President-Strategic Communications at Vertex Pharmaceuticals, Inc., Vice President at Feinstein Kean Healthcare, and Executive Vice President at Porter Novelli Life Sciences LLC.
Ms. Brum obtained an MBA from Simmons University and completed her undergraduate degree at Wellesley College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
0,26% | 28.03.2024 | 39 998 ( 0,26% ) | 9 560 $ | 30.04.2024 |
Aktive Positionen von Lynne Brum
Unternehmen | Position | Beginn |
---|---|---|
YIELD10 BIOSCIENCE, INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Lynne Brum
Unternehmen | Position | Ende |
---|---|---|
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Corporate Officer/Principal | 01.01.2011 |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Corporate Officer/Principal | 01.01.2009 |
VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 09.06.2006 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lynne Brum
Simmons University | Masters Business Admin |
Wellesley College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
YIELD10 BIOSCIENCE, INC. | Process Industries |
Private Unternehmen | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Commercial Services |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Commercial Services |